Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| Yesterday 6:00 PM View:  | An2 Therapeutics, Inc. (ANTX) | 20-Nov-24 | Purchase | 50,000 | $1.16 | $57,870.00 | 5% 1.05M to 1.1M | |
| Yesterday 6:00 PM View: | An2 Therapeutics, Inc. (ANTX) | 19-Nov-24 | Private Purchase | 150,000 | $1.04 | $155,257.00 | 17% 899.86K to 1.05M | |
| 17-Jan-24 5:03 PM View: | An2 Therapeutics, Inc. (ANTX) | 12-Jan-24 | Private Sale (Planned) | 1,425 | $21.92 | $31,228.80 | (< 1%) 901.29K to 899.86K | |
| 12-Jan-24 5:08 PM View: | An2 Therapeutics, Inc. (ANTX) | 10-Jan-24 | Private Sale (Planned) | 3,669 | $21.93 | $80,443.20 | (< 1%) 904.96K to 901.29K | |
| 31-Mar-22 8:15 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Mar-22 | Conversion | 751,621 | -- | -- | 100% 0 to 751.62K | |
| 31-Mar-22 8:15 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Mar-22 | Market Purchase | 153,334 | $15.00 | $2,300,010.00 | 20% 751.62K to 904.96K |